1471 - 1480 of 8825 Results
Title
Year
-
OPENTitle: Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 215Issue #: 1Start Page: 5End Page: 19Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2008.09.003Best OA location URL: http://doi.org/10.1016/j.expneurol.2008.09.003Citation Count: 240
-
OPENTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.03.032Citation Count: 68
-
OPENTitle: FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 20Issue #:Start Page: 572End Page: 579Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nicl.2018.08.006Best OA location URL: https://doi.org/10.1016/j.nicl.2018.08.006Citation Count: 83
- Effects of a higher dose of near-infrared light on clinical signs and neuroprotection in a monkey model of Parkinson's disease2016RESTRICTEDTitle: Effects of a higher dose of near-infrared light on clinical signs and neuroprotection in a monkey model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 19End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2016.07.005Citation Count: 31
-
OPENTitle: Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 218Issue #: 1Start Page: 154End Page: 161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2009.04.023Best OA location URL: http://doi.org/10.1016/j.expneurol.2009.04.023Citation Count: 156
- Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia2010OPENTitle: Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementiaJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 225Issue #: 1Start Page: 210End Page: 218Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.06.017Citation Count: 198
-
OPENTitle: Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 13Issue #: 2Start Page: 141End Page: 149Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70293-xBest OA location URL: http://doi.org/10.1016/S1474-4422(13)70293-XCitation Count: 670
- A trio has turned into a quartet: DJ-1 interacts with the IP3R-Grp75-VDAC complex to control ER-mitochondria interaction2020RESTRICTEDTitle: A trio has turned into a quartet: DJ-1 interacts with the IP3R-Grp75-VDAC complex to control ER-mitochondria interactionJournal Name: Cell CalciumPublisher: Elsevier BVVol: 87Issue #:Start Page: 102186End Page: 102186Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ceca.2020.102186Citation Count: 52
- Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics2005RESTRICTEDTitle: Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinicsJournal Name: Movement DisordersPublisher: WileyVol: 21Issue #: 4Start Page: 519End Page: 523Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.20751Citation Count: 90
-
RESTRICTEDTitle: Therapeutic directions for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page: S152End Page: 4Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22790Best OA location URL: https://europepmc.org/articles/pmc3110693?pdf=renderCitation Count: 7